Recent Finacing
Recent Raise
Supercede Therapeutics is a biotech startup developing orally bioavailable small-molecule ACTRII kinase inhibitors for obesity, leveraging AI/ML-enabled target discovery and in-licensed programs with university-originated IP.
Focus Areas
Funding round